Search results
Results from the WOW.Com Content Network
Revenue. $54.2 million (2019) [1] Number of employees. 400. Website. twistbioscience .com. Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. [2] Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
Emily Leproust is an American scientist and entrepreneur. She is the CEO and co-founder [1] of Twist Bioscience, a public company working on DNA synthesis. The company harnesses synthetic biology, providing tools to manufacture insulin from yeast, to tackle malaria, [2] produce spider silk at scale [3] or store information on DNA.
Twist Bioscience Corporation ( NASDAQ:TWST ) shareholders might be concerned after seeing the share price drop 29% in... If You Had Bought Twist Bioscience (NASDAQ:TWST) Stock A Year Ago, You ...
Twist Bioscience (TWST) delivered earnings and revenue surprises of 16.92% and 9.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
President & CEO of Twist Bioscience Corp (30-Year Financial, Insider Trades) Emily M. Leproust (insider trades) sold 5,000 shares of TWST on 12/22/2020 at an average price of $160.12 a share.
en.wikipedia.org
SAN FRANCISCO (AP) _ Twist Bioscience Corp. (TWST) on Wednesday reported a loss of $31.2 million in its fiscal fourth quarter. On a per-share basis, the San Francisco-based company said it had a ...
The Genome Project - Write (also known as GP-Write) is a large-scale collaborative research project (an extension of Genome Projects, aimed at reading genomes since 1984) that focuses on the development of technologies for the synthesis and testing of genomes of many different species of microbes, plants, and animals, including the human genome ...